March 07, 2025

Early Excellence in Science Award for Ivana Winkler

Early Excellence in Science Award for Ivana Winkler

The Bayer Foundation’s Early Excellence in Science Award 2024 in the category of Data Science goes to Ivana Winkler of the German Cancer Research Center (DKFZ). Winkler’s work uncovered the unexpected effect of female reproductive capacity: the constantly recurring remodeling of the organs of the female reproductive tract during the sexual cycle leads to fibrosis and chronic inflammation over the years.

Source: Bayer Foundation

The organs of the female reproductive tract undergo extensive remodeling during each monthly cycle in preparation for ovulation or pregnancy. The effects of this recurring remodeling on the affected organs, including the ovaries, fallopian tubes, uterus, cervix, and vagina, have not yet been sufficiently researched. Much of the work that has been done so far has been based on purely microscopic examinations or has only looked at individual organs or the activity of certain genes.

Ivana Winker, a postdoc in the Molecular and Computational Prevention Division at the DKFZ, has systematically examined the changes in gene activity and morphology in mice in all affected organs during each phase of the cycle – at the level of individual cells and in spatial resolution. This enabled her and her colleagues to compile a cell atlas of the female reproductive tract.

Many physiological reproductive events, such as ovulation, menstruation or implantation of the fertilized egg, show characteristic signs of inflammation. The molecular signaling pathways and molecules that maintain this inflammation largely originate from connective tissue cells, one of the main sources of pro-inflammatory messengers.

A remarkable feature of the female reproductive tract is its ability to rapidly clear these cyclically occurring inflammations and restore normal reproductive function. Inflammation that does not resolve, coupled with other signs of aging, can become chronic and lead to fibrosis.

Based on their results, Winkler and colleagues developed a model in which repeated remodeling of the reproductive tract over the reproductive lifespan drives a gradual, age-related development of fibrosis and chronic inflammation. They were able to test this hypothesis directly by using drugs to block the estrous cycle. This cycle blockade reduced progressive fibrosis, while other aging processes continued to proceed normally.

The atlas highlights how the interplay of estrus cycling, pregnancy, and aging sculpts the female reproductive tract. For a long time, it was assumed that these events left no traces or scars in the affected organs. The work of Winkler and colleagues reveals the unexpected price of female reproductive capacity, which is paid for by the constant remodeling of the female reproductive tract. Although these results have so far only been observed in mice, they have great potential for, among other things, developing new therapies to combat cancer in the reproductive organs of women.

The Bayer Foundation grants the Early Excellence in Science Awards, which are endowed with 10,000 euros each, annually to outstanding young scientists and physicians at the beginning of their academic and clinical research careers. The award is given in four categories: biology, chemistry, medicine and data science.

Our latest News

discover more
Nobel-Potential Discovery from VectorBuilder Scientists Reveals Fundamental Mechanisms of Development

Nobel-Potential Discovery from VectorBuilder Scientists Reveals Fundamental Mechanisms of Development

Chicago, April 21, 2026 – One of the most fundamental questions in biology is how a single fertilized egg produces the diverse cell types making up the body – from neurons and skin to muscle and blood – that bear the same genetic blueprint but distinct expression patterns. Now, a research team lead by Dr. Bruce Lahn, […]

Wo Zukunft entsteht: Deutschlands „Innovationsmaschinenräume“ präsentieren sich auf der re:publica 2026

Wo Zukunft entsteht: Deutschlands „Innovationsmaschinenräume“ präsentieren sich auf der re:publica 2026

Wie kann aus wissenschaftlicher Forschung eine konkrete medizinische Therapie entstehen? Im Maschinenraum der Life Sciences leistet bioRN Life Science Cluster genau das: Unter anderem beim Thema Frauengesundheit Heidelberg, 30 April 2026: Frauen sterben früher und werden oft schlechter therapiert. Der Grund dafür: Die medizinische Forschung und Entwicklung waren lange Zeit überwiegend auf männliche Populationen ausgerichtet. […]

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

Global CDMO recognized for exceptional quality systems and regulatory track record; named finalist in Excellence in Client Service & Partnership and Manufacturing Operations categories SEATTLE – April 27, 2026 – AGC Biologics, your friendly CDMO expert, is the 2026 recipient of the Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance. The award recognizes the […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp